Silvia B. Boscardin

Sao Paulo, SP, Brazil

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 68 publications

Synergistic effect of AddaS03 and poly I:C adjuvants on antibody titers and Th1-biased T cell responses following RBD vaccination in BALB/c mice.

Synergistic effect of AddaS03 and poly I:C adjuvants on antibody titers and Th1-biased T cell responses following RBD vaccination in BALB/c mice.

Journal: Vaccine

Published: June 23, 2026

Molecular Characterization of Calu-3 Cells from Submerged to Air-Liquid Interface to Model Lung Infections.

Molecular Characterization of Calu-3 Cells from Submerged to Air-Liquid Interface to Model Lung Infections.

Journal: Journal of proteome research

Published: January 28, 2026

Dengue Vaccines.

Dengue Vaccines.

Journal: Current topics in microbiology and immunology

Published: August 12, 2025

An innovative nasal nanovaccine against SARS-CoV-2 induces systemic and upper airway immunity controlling viral replication.

An innovative nasal nanovaccine against SARS-CoV-2 induces systemic and upper airway immunity controlling viral replication.

Journal: NPJ vaccines

Published: July 10, 2025

Adjuvant combination and antigen multimerization shape neutralizing antibody and T cell responses to a SARS-CoV-2 RBD subunit vaccine.

Adjuvant combination and antigen multimerization shape neutralizing antibody and T cell responses to a SARS-CoV-2 RBD subunit vaccine.

Journal: Frontiers in immunology

Published: April 12, 2025

Corrigendum: Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals.

Corrigendum: Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals.

Journal: Frontiers in immunology

Published: March 22, 2025

Murine antibody 4B1D3 exhibits broad cross-reactivity and neutralizing activity against SARS-CoV-2 variants.

Murine antibody 4B1D3 exhibits broad cross-reactivity and neutralizing activity against SARS-CoV-2 variants.

Journal: Virology

Published: March 20, 2025

Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil: Differential neutralization of SARS-CoV-2 omicron variants.

Neutralizing antibody responses after a two-dose regimen with BNT162b2, CoronaVac or ChAdOx1-S in Brazil: Differential neutralization of SARS-CoV-2 omicron variants.

Journal: Clinical immunology (Orlando, Fla.)

Published: January 03, 2025

Protective role of anti-SARS-CoV-2 antibody responses against vital organ related long COVID symptoms.

Protective role of anti-SARS-CoV-2 antibody responses against vital organ related long COVID symptoms.

Journal: Scientific reports

Published: October 29, 2024

Macrophage Protein Disulfide Isomerase Increases Infection by Leishmania amazonensis.

Macrophage Protein Disulfide Isomerase Increases Infection by Leishmania amazonensis.

Journal: Cell biology international

Published: August 19, 2024

P.1 and P.2 SARS-CoV-2 Brazilian variants activate the unfolded protein response with a time and pathway specificity.

P.1 and P.2 SARS-CoV-2 Brazilian variants activate the unfolded protein response with a time and pathway specificity.

Journal: Journal of proteomics

Published: August 15, 2024

Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals.

Anti-RBD IgG antibodies from endemic coronaviruses do not protect against the acquisition of SARS-CoV-2 infection among exposed uninfected individuals.

Journal: Frontiers in immunology

Published: March 06, 2024

Showing 1-12 of 68

Last Updated: 09/26/2026